Results 211 to 220 of about 713,550 (341)

Prevalence of transthyretin cardiac amyloidosis in undifferentiated heart failure with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 1176-1182, April 2025.
Abstract Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM) is an increasinglyrecognized cause of heart failure with preserved ejection fraction (HFpEF), which may be diagnosed non‐invasively using 99mTc 3,3‐diphosphono‐1,2‐propanodicarboxylic acid (DPD) scintigraphy‐based diagnostic criteria.
L. Healy, G. Giblin, A. Gray, N. Starr, L. Murphy, D. O'Sullivan, E. Kavanagh, C. Howley, C. Tracey, E. Morrin, A. McDaid, A. Clarke, J.O. O'Neill, E. Joyce, M. O'Connell, N. G. Mahon   +15 more
wiley   +1 more source

Markers in Acute Coronary Syndrome: Distal Coronary Embolism at Percutaneous Coronary Intervention. [PDF]

J Cardiovasc Dev Dis
Semerdzhieva NE, Dimitrov S, Tsakova A, Gospodinova M, Atanasov P, Lozanova V.   +5 more
europepmc   +1 more source

Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome: Systematic Review and Recommendations A Scientific Statement From the American Heart Association

Circulation, 2014
J. Lichtman, E. S. Froelicher, James A. Blumenthal, R. Carney, Lynn V. Doering, Nancy Frasure-Smith, K. Freedland, Allan S. Jaffe, Erica C. Leifheit-Limson, David S. Sheps, V. Vaccarino, L. Wulsin   +11 more
semanticscholar   +1 more source

Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb Study

, 2000
Darren K. McGuire
openalex   +1 more source

Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology Recommendations of the Task Force of the European Society of Cardiology [PDF]

, 2000
M Bertrand
openalex   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Effect of Plasma Homocysteine Concentration on Early and Late Events in Patients With Acute Coronary Syndromes

, 2000
P J Stubbs, Mohamed Al-Obaidi, Ronán Conroy, MusB, Paul Collinson, MRCPath MRCPath, Ian Graham, Frcpi, Mark I. M. Noble   +8 more
openalex   +1 more source

Randomized, Double‐blind, Placebo‐controlled Trial of Diazepam, Nitroglycerin, or Both for Treatment of Patients with Potential Cocaine‐associated Acute Coronary Syndromes [PDF]

, 2000
Brigitte M. Baumann, Jeanmarie Perrone, Sarah E. Hornig, Frances S. Shofer, Judd E. Hollander   +4 more
openalex   +1 more source

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

ESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri, Ahmad Gharaibeh, Lubika Nkashama, Abdelrahman Abushouk, Osama Abushawer, Amir Mehdizadeh‐Shrifi, Bianca Honnekeri, Cassandra Calabrese, Venu Menon, Pauline Funchain, Patrick Collier, Diego Sadler, Rohit Moudgil   +12 more
wiley   +1 more source

Acute Coronary Syndrome: Considerations Regarding Pregnancy [Letter]. [PDF]

Int J Womens Health
Fei K, Jiang X, Huang J.
europepmc   +1 more source